Updated Clinical Review: Perioperative Use of Tranexamic Acid in Orthopedics and Other Surgeries

PP BH, S Patel, YH Lai - Advances in Anesthesia, 2023 - advancesinanesthesia.com
INTRODUCTION Tranexamic acid (TXA) or trans-4-amino-methyl-cyclohexane-carbonic
acid is a synthetic analog derivative of amino acid lysine that inhibits fibrinolysis by …

The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of …

N Suzuki, N Suzuki, Y Kawaguchi, S Okamoto… - Thrombosis …, 2023 - Springer
Background Tranexamic acid (TXA) is an antifibrinolytic drug that blocks lysine-binding sites
on the profibrinolytic enzyme plasminogen. Aortic diseases with chronic consumption …

Preoperative coil embolization of side branches and postoperative antifibrinolytic therapy in endovascular aneurysm repair: a propensity score analysis

A Hiraoka, G Chikazawa, A Ishida, T Totsugawa… - Journal of Vascular and …, 2017 - Elsevier
Purpose To demonstrate feasibility and efficacy of preoperative coil embolization of side
branches and postoperative tranexamic acid (TXA) therapy for management of type II …

Effects of tranexamic acid on coagulation indexes of patients undergoing heart valve replacement surgery under cardiopulmonary bypass

F Liu, D Xu, K Zhang, J Zhang - International Journal of …, 2016 - journals.sagepub.com
This study aims to explore the effects of tranexamic acid on the coagulation indexes of
patients undergoing heart valve replacement surgery under the condition of …

Randomized controlled trial of oral tranexamic acid intervention for the prevention of Type II endoleak after endovascular abdominal aneurysm repair

Y Imaeda, H Ishibashi, Y Orimoto… - Annals of Thoracic and …, 2022 - jstage.jst.go.jp
Purpose: The purpose of this study was to evaluate tranexamic acid (TA) for the prevention
of type II endoleak (EL2) at a high level of evidence by a randomized controlled trial …

The Association Between the D-dimer Level at 1 Year After EVAR and Sac Diameter Change in Patients With Persistent Type 2 Endoleak

M Sugimoto, T Sato, S Ikeda, Y Kawai… - Journal of …, 2023 - journals.sagepub.com
Purpose: Recent studies suggested that continuous clotting renewal in thrombi plays a
central role in sac enlargement after endovascular aneurysm repair (EVAR). We reviewed …

The use of an anti-fibrinolytic agent to reduce endoleak following endovascular repair of multiple aortic aneurysms

T Uzuka, M Nakamura, Y Kuroda… - … and thoracic surgery, 2015 - academic.oup.com
This paper reports on the therapeutic use of tranexamic acid in an elderly patient with severe
comorbidities that precluded even endovascular reintervention. Orally administered …

Factors Influencing on the Aneurysm Sac Shrinkage after Endovascular Abdominal Aortic Aneurysm Repair by the Analysis of the Patients with the Aneurysm Sac …

A Aoki, K Maruta, T Masuda, T Omoto - Annals of Vascular Diseases, 2023 - jstage.jst.go.jp
Objectives: The aneurysmal sac shrinkage has been reported as the strong predictor of
favorable long-term outcome after endovascular aneurysm repair (EVAR). We evaluated the …

氨甲环酸用于全膝关节置换降低失血量的有效性及安全性

曹万军, 朱绍灵, 刘显东, 唐承杰, 郑金文, 陈星宇… - 中国组织工程研究, 2015 - cjter.com
背景: 氨甲环酸是一种人工合成的抗纤维蛋白溶解的药物, 可以经静脉有效的控制全膝关节置换
后失血. 目的: 观察氨甲环酸对初次行单侧全膝关节置换患者置换后失血的有效性及安全性 …

[HTML][HTML] High aneurysm wall enhancement values are associated with late sac shrinkage after endovascular repair of abdominal aortic aneurysms

S Okata, K Hoshina, K Miyahara, M Matsukura, T Akai… - Medicine, 2021 - journals.lww.com
High aneurysm wall enhancement values are associated with la... : Medicine High aneurysm
wall enhancement values are associated with late sac shrinkage after endovascular repair of …